Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Sell

Security Buy Sell Buy (1M) Sell (1M) ▼ Price Target price Potential
Trevena Inc. 1 14 0 2 €0.36 €8.37 2250.112%
Cytomx Therapeutics Inc 1 2 1 2 €1.75 €25.50 1359.645%
Revance Therapeutics Inc. 1 2 0 2 €3.08 €3.50 13.636%
Organovo Holdings Inc. 0 7 0 2 €0.88 - -
Fate Therapeutics Inc. 4 3 1 1 €3.84 €8.27 115.154%
Synthetic Biologics Inc. 0 1 0 1 €0.35 - -
Minerva Neurosciences Inc. 1 5 0 0 €2.38 €7.00 194.118%
Ocuphire Pharma Inc. 6 1 1 0 €1.55 €18.37 1081.853%
Atara Biotherapeutics Inc. 2 3 0 0 €0.52 €3.00 481.621%
Eagle Pharmaceuticals Inc 0 1 0 0 €4.44 - -
Palisade Bio Inc. 3 1 2 0 €0.34 €21.06 6072.333%
Gritstone Oncology Inc 3 2 1 0 €0.71 €6.43 801.121%
Anavex Life Sciences Corp 0 2 0 0 €3.55 - -
Agenus Inc. 3 2 1 0 €0.41 €22.25 5276.897%
Aspira Womens Health Inc. 0 1 0 0 €2.66 - -
Bellicum Pharmaceuticals Inc. 0 13 0 0 €0.064 - -
Coherus Bioscien. 2 2 0 0 €1.93 €3.00 55.199%